
Afya fell 25.0% from $14.22 to $10.67, behind the S&P 500's +10.5%. Its worst day was Oct 26 (−29.5%), and its low came Nov 5 at $10.15.
Story events cover the past 12 months · Times ET
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.38 beat the $0.31 estimate on $170.4M revenue (est. $168.8M); FY revenue guidance of $626.7M–$643.8M against the $687.1M consensus.
+1.4% · S&P 500 −1.7%
EPS of $0.42 beat the $0.37 estimate on $169.1M revenue (est. $177.1M); FY revenue guidance of $731.7M–$759.5M against the $764.0M consensus.
+1.9% · S&P 500 −0.6%
Afya closed at its highest level of the year, 11.5% above where the year started.
+0.7% · S&P 500 +1.2%
EPS of $0.55 beat the $0.54 estimate on $192.3M revenue (est. $191.9M); FY revenue guidance of $731.7M–$759.5M against the $760.3M consensus.
+0.1% · S&P 500 +0.8%
EPS of $0.44 missed the $0.46 estimate on $192.2M revenue (est. $192.8M); FY revenue guidance of $750.2M–$778.7M against the $781.6M consensus.
+3.2% · S&P 500 −0.2%
Afya shares rose 8.9%, while the S&P 500 rose 0.7%.
+8.9%, the year's best day · S&P 500 +0.7%
Afya shares fell 29.5%, while the S&P 500 rose 0.7%.
−29.5%, the year's worst day, on 2M shares, the year's heaviest volume · S&P 500 +0.7%
Where it ended: a close of $10.67 on Nov 9, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $0.72, revenue est. $180.6M).
Nothing in the past 12 months.
All AFYA dividend history